Research that Identifies
Undiscovered Value in the MicroCap Market

First Choice Healthcare Solutions, Inc.

First Choice Healthcare Solutions Email List: Click to Subscribe

View Company Website: Click to View

Market Data: Yahoo Finance, Bloomberg, SEC

Report Link: Initial Research Report (Dated 06/26/2018)

Symbol: FCHS
Analyst: Howard Halpern
Taglich Rating: Speculative Buy
Price Target: $2.00
Time Horizon: 12 Months
Rating Established: June 26, 2018
Price When Established: $1.29
Most Recent Report: June 26, 2018
Price When Issued: $1.29

What's New

First Choice Healthcare Solutions Reports 2Q18 Results

On August 15, 2018, First Choice Healthcare Solutions reported 2Q18 results for the three-months ended June 30, 2018.

FCHS reported total revenue increased 14.7% to $9.4 million due to a 15.7% increase in net patient service revenue to $8.8 million. The company reported net income of $432,000 or $0.01 per share compared to a net loss of $132,000 or break even per share, on total revenue of $8.2 million.

2Q18 growth was driven by 11.2% growth in surgeries to 954.

We forecasted 2Q18 revenue of $8.8 million and net income of $184,000 or $0.01 per share.

Company Description

First Choice Healthcare Solutions, Inc., headquartered in Melbourne, Florida operates a network of localized, integrated care platforms comprised of non-physician-owned medical centers (First Choice Medical Group, The B.A.C.K. Center, and Crane Creek Surgery Center). The company is primarily focused on treating and servicing patients in orthopaedics and spinal surgeries, as well as related diagnostic imaging (X-rays and MRI’s) and ancillary services such as physical and occupational therapy.

Company Reports

Initial Research Report (Dated June 26, 2018)


Please view our current disclosure and disclaimer on our most recent research report.